Cancer Models—Multiparametric Applications of Clinical MRI in Rodent Hepatic Tumor Model
Author:
Publisher
Humana Press
Link
http://link.springer.com/content/pdf/10.1007/978-1-61779-219-9_26
Reference27 articles.
1. Antoine E., Pauwels C., Verrelle P., Lascaux V., and Poupon M. F. (1988) In vivo emergence of a highly metastatic tumour cell line from a rat rhabdomyosarcoma after treatment with an alkylating agent. Br J Cancer 57, 469–474.
2. Hermens A. F. and Barendsen G. W. (1967) Cellular proliferation patterns in an experimental rhabdomyosarcoma in the rat. Eur J Cancer 3, 361–369.
3. Denekamp J. (1992) The choice of experimental models in cancer research: the key to ultimate success or failure? NMR Biomed 5, 234–237.
4. Thoeny H. C., De Keyzer F., Chen F., et al. (2005) Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats. Radiology 234, 756–764.
5. Kerbel R. S. (2008) Tumor angiogenesis. N Engl J Med 358, 2039–2049.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparison of the Efficiency of Conventional Diffusion, Diffusion Tensor Imaging, and Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Perfusion Imaging in the Evaluation of Liver Fibrosis;Kocaeli Üniversitesi Sağlık Bilimleri Dergisi;2021-11-01
2. Tumor resistance to vascular disrupting agents: mechanisms, imaging, and solutions;Oncotarget;2016-01-22
3. High-field small animal magnetic resonance oncology studies;Physics in Medicine and Biology;2013-12-30
4. Diverse Responses to Vascular Disrupting Agent Combretastatin A4 Phosphate: A Comparative Study in Rats with Hepatic and Subcutaneous Tumor Allografts Using MRI Biomarkers, Microangiography, and Histopathology;Translational Oncology;2013-02
5. Enhanced Antitumor Efficacy of a Vascular Disrupting Agent Combined with an Antiangiogenic in a Rat Liver Tumor Model Evaluated by Multiparametric MRI;PLoS ONE;2012-07-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3